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INTRODUCTION: Gold nanorods (AuNRs) can find many biomedical applications 
including photothermal therapy 
[1]
. AuNRs are normally coated with cetyltrimethyl 
ammonium bromide (CTAB) when synthesized via seed-mediated growth, resulting in 
cytotoxicity and low stability which hinder their medical applications. Coating silica on 
AuNRs may solve the problem and also makes it possible to conjugate targeting ligands 
to AuNRs 
[2]
. But the shape and thickness control and functionalization of silica shell are 
the challenges. The reported methods for coating silica often lack reproducibility and also 
require precise control of CTAB concentration in AuNR stock solution 
[3]
. This 
investigation developed a facile method to make folic acid modified AuNR core-
mesoporous silica shell (AuNR@mSiO2) nanodevices for anti-cancer applications. 
MATERIALS AND METHODS: AuNRs were synthesized by a modified seed-
mediated growth method using binary surfactants. To form mesoporous silica shell on 
AuNRs, highly diluted tetraethyl orthosilicate (TEOS) in ethanol was the precursor and 
surfactants adsorbed on AuNR surface were used. Different amounts of TEOS/ethanol 
solution and CTAB were investigated for forming silica shell. To functionalize the 
surface of AuNR@mSiO2 nanoparticles (NPs) with amino groups, NPs were refluxed in 
boiled ethanol containing (3-aminopropyl) triethoxysilane (APTES). Folic acid was then 
conjugated to amino groups on silica shell. After removal of CTAB via refluxing in 
NH3NO3 and ethanol solution, doxorubicin hydrochloride (DOX, anticancer drug) was 
loaded into mesopores of NPs. Drug release behaviours were studied. 
RESULTS AND DISCUSSION: There are problems for the seed-mediated growth of 
AuNRs using surfactant CTAB. To improve the uniformity and tune their surface 
plasmon resonance wavelength, binary surfactants could be used 
[4]
. This investigation 
used a binary surfactant (sodium oleate and CTAB) in the growth solution to tune the 
dimensions of AuNRs. The synthesized AuNRs showed high uniformity with 70 nm in 
length and 25 nm in diameter with negligible impurities (e.g. spheres) (Fig.1a). Previous 
studies hardly obtained a highly uniform silica coating and proper thickness 
[5]
. In this 
investigation, a modified method was used. Also, through optimizing the process and 
concentration of reactants and surfactants, AuNR@mSiO2 NPs had a uniform and 
controllable thickness for the silica coating (Fig.1b). Mesopores in this coating were 
observed under TEM. After silica coating, the maximum longitudinal SPR wavelength 
red-shifted slightly but was still in the near-infrared region. Upon laser irradiation, 
AuNR@mSiO2 suspensions exhibited temperature increases (Fig.2a) due to the 
photothermal effect of AuNR core. Drug release from AuNR@mSiO2 was studied at 
different temperatures with or without laser irradiation. Under laser irradiation, drug 
release was promoted due to enhanced diffusion of drugs caused by temperature increase 
(Fig.2b). 
CONCLUSION: A facile three-step method was developed to fabricate folic acid 
modified AuNR core-mesoporous silica shell (AuNR@mSiO2) NPs as multifunctional 
nanodevice for anti-cancer applications. The synthesized AuNRs were uniform in size 
and shape and the mesoporous silica shell formed on AuNRs was also uniform. The anti-
cancer drug could be stored in the mesopores of the silica coating. It could be released in 
a controlled manner at the body temperature or under laser irradiation. 
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